At the end of July, the Shenzhen Stock Exchange released an announcement on the results of the 7th review meeting of the GEM Listing Committee. Zhejiang Weikang Pharmaceutical (Wecome Pharma) passed the meeting successfully. According to the prospectus, the offering will raise RMB 540 million yuan (USD $77.4 million), of which RMB 359 million yuan (USD $51.5) will be used for the first phase of the pharmaceutical health industrial park project construction.
The project covers an area of about 200 acres, with a total construction area of nearly 200,000 square meters, with 9 construction projects planned to be built, including a pharmaceutical quality inspection building, an intelligent Chinese medicine extraction building, a modern Chinese medicine beverage factory, a modern pharmaceutical logistics center, a national key laboratory and a research and development center. (Source: Eastmoney Finance)